Journal of Lipid Research 2014-12-01

Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome.

Fabiana Rached, Raul D Santos, Laurent Camont, Marcio H Miname, Marie Lhomme, Carolane Dauteuille, Sora Lecocq, Carlos V Serrano, M John Chapman, Anatol Kontush

Index: J. Lipid Res. 55(12) , 2509-20, (2014)

Full Text: HTML

Abstract

To evaluate functional and compositional properties of HDL in subjects from a kindred of genetic apoA-I deficiency, two homozygotes and six heterozygotes, with a nonsense mutation at APOA1 codon -2, Q[-2]X, were recruited together with age- and sex-matched healthy controls (n = 11). Homozygotes displayed undetectable plasma levels of apoA-I and reduced levels of HDL-cholesterol (HDL-C) and apoC-III (5.4% and 42.6% of controls, respectively). Heterozygotes displayed low HDL-C (21 ± 9 mg/dl), low apoA-I (79 ± 24 mg/dl), normal LDL-cholesterol (132 ± 25 mg/dl), and elevated TG (130 ± 45 mg/dl) levels. Cholesterol efflux capacity of ultracentrifugally isolated HDL subpopulations was reduced (up to -25%, P < 0.01, on a glycerophospholipid [GP] basis) in heterozygotes versus controls. Small, dense HDL3 and total HDL from heterozygotes exhibited diminished antioxidative activity (up to -48%, P < 0.001 on a total mass basis) versus controls. HDL subpopulations from both homozygotes and heterozygotes displayed altered chemical composition, with depletion in apoA-I, GP, and cholesteryl ester; enrichment in apoA-II, free cholesterol, and TG; and altered phosphosphingolipidome. The defective atheroprotective activities of HDL were correlated with altered lipid and apo composition. These data reveal that atheroprotective activities of HDL particles are impaired in homozygous and heterozygous apoA-I deficiency and are intimately related to marked alterations in protein and lipid composition. Copyright © 2014 by the American Society for Biochemistry and Molecular Biology, Inc.

Related Compounds

Structure Name/CAS No. Articles
Formic Acid Structure Formic Acid
CAS:64-18-6
Formic acid ammonium salt Structure Formic acid ammonium salt
CAS:540-69-2
L-serine Structure L-serine
CAS:56-45-1
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE Structure 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE
CAS:18194-24-6
1-Palmitoyl-2-oleoyl-sn-glycero-3-PC Structure 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC
CAS:26853-31-6
1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE Structure 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE
CAS:17708-90-6
1-OCTADECANOYL-2-[CIS-9-OCTADECENOYL]-SN-GLYCERO-3-PHOSPHOCHOLINE Structure 1-OCTADECANOYL-2-[CIS-9-OCTADECENOYL]-SN-GLYCERO-3-PHOSPHOCHOLINE
CAS:56421-10-4
1,2-Distearoyl-sn-glycero-3-phosphocholine Structure 1,2-Distearoyl-sn-glycero-3-phosphocholine
CAS:816-94-4
Colfosceril palmitate Structure Colfosceril palmitate
CAS:63-89-8
O-Phosphorylethanolamine Structure O-Phosphorylethanolamine
CAS:1071-23-4